{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:47:54Z","timestamp":1790891274091,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,9,23]],"date-time":"2008-09-23T00:00:00Z","timestamp":1222128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["In Vitro Cell.Dev.Biol.-Animal"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s11626-008-9138-5","type":"journal-article","created":{"date-parts":[[2008,9,22]],"date-time":"2008-09-22T21:01:39Z","timestamp":1222117299000},"page":"397-406","source":"Crossref","is-referenced-by-count":16,"title":["Correction of glycogenosis type 2 by muscle-specific lentiviral vector"],"prefix":"10.1007","volume":"44","author":[{"given":"Emmanuel","family":"Richard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Douillard-Guilloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Caillaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,23]]},"reference":[{"key":"9138_CR1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/7.1.53","volume":"7","author":"A. G. Bijvoet","year":"1998","unstructured":"Bijvoet, A. G.; van de Kamp, E. H.; Kroos, M. A.; Ding, J. H.; Yang, B. Z.; Visser, P.; Bakker, C. E.; Verbeet, M. P.; Oostra, B. A.; Reuser, A. J.; Van der Ploeg, A. T. Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease. Hum. Mol. Genet 7: 53\u201362; 1998 doi: 10.1093\/hmg\/7.1.53 .","journal-title":"Hum. Mol. Genet"},{"key":"9138_CR2","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI30953","volume":"117","author":"M. Cavazzana-Calvo","year":"2007","unstructured":"Cavazzana-Calvo, M.; Fischer, A. Gene therapy for severe combined immunodeficiency: are we there yet? J. Clin. Invest. 117: 1456\u20131465; 2007 doi: 10.1172\/JCI30953 .","journal-title":"J. Clin. Invest."},{"key":"9138_CR3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.mt.6300060","volume":"15","author":"A. H. Chang","year":"2007","unstructured":"Chang, A. H.; Sadelain, M. The genetic engineering of hematopoietic stem cells: the rise of lentiviral vectors, the conundrum of the LTR, and the promise of lineage-restricted vectors. Mol. Ther. 15: 445\u2013456; 2007 doi: 10.1038\/sj.mt.6300060 .","journal-title":"Mol. Ther."},{"key":"9138_CR4","volume-title":"Retroviruses","author":"J. M. Coffin","year":"1997","unstructured":"Coffin, J. M.; Hugues, S. H.; Varmus, H. E. Retroviruses. Cold Spring Harbour Laboratory Press, Cold Spring Harbor, New York;1997."},{"key":"9138_CR5","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1073\/pnas.76.9.4526","volume":"76","author":"G. G. D\u2019Ancona","year":"1979","unstructured":"D\u2019Ancona, G. G.; Wurm, J.; Croce, C. M. Genetics of type II glycogenosis: assignment of the human gene for acid alpha-glucosidase to chromosome 17. Proc. Natl. Acad. Sci. USA 76: 4526\u20134529; 1979 doi: 10.1073\/pnas.76.9.4526 .","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9138_CR6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1096\/fj.02-0671fje","volume":"17","author":"R. Draghia-Akli","year":"2003","unstructured":"Draghia-Akli, R.; Ellis, K. M.; Hill, L. A.; Malone, P. B.; Fiorotto, M. L. High-efficiency growth hormone-releasing hormone plasmid vector administration into skeletal muscle mediated by electroporation in pigs. FASEB J 17: 526\u2013528; 2003.","journal-title":"FASEB J"},{"key":"9138_CR7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/mthe.2002.0580","volume":"5","author":"T. J. Fraites Jr.","year":"2002","unstructured":"Fraites, T. J. Jr.; Schleissing, M. R. R.; Shanely, A.; Walter, G. A.; Coutier, D. A.; Zolotukhin, I.; Pauly, D. F.; Raben, N.; Plotz, P. H.; Powers, S. K.; Kessler, P. D.; Byrne, B. J. Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors. Mol. Ther 5: 571\u2013578; 2002 doi: 10.1006\/mthe.2002.0580 .","journal-title":"Mol. Ther"},{"key":"9138_CR8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ymthe.2005.04.024","volume":"12","author":"L. M. Franco","year":"2005","unstructured":"Franco, L. M.; Sun, B.; Yang, X.; Bird, A.; Zhang, H.; Schneider, A.; Brown, T.; Young, S. P.; Clay, T. M.; Amalfitano, A.; Chen, Y. T.; Koeberl, D. D. Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II. Mol. Ther 12: 876\u2013884; 2005 doi: 10.1016\/j.ymthe.2005.04.024 .","journal-title":"Mol. Ther"},{"key":"9138_CR9","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1182\/blood.V94.10.3349.422k05_3349_3357","volume":"94","author":"S. Halene","year":"1999","unstructured":"Halene, S.; Wang, L.; Cooper, R. M.; Bockstoce, D. C.; Robbins, P. B.; Khon, D. B. Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. Blood 94: 3349\u20133357; 1999.","journal-title":"Blood"},{"key":"9138_CR10","first-page":"3389","volume-title":"The metabolic and molecular bases of inherited diseases","author":"R. Hirschhorn","year":"2001","unstructured":"Hirschhorn, R.; Reuser, A. J. J. Glycogen storage disease type II: acid \u03b1-glucosidase (acid maltase) deficiency. In: Scriver, C. R.; Baudet, A. L.; Sly W. S.; Valle, D. (eds) The metabolic and molecular bases of inherited diseases. McGraw-Hill, New York, pp 3389\u20133420; 2001."},{"key":"9138_CR11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ng1197-314","volume":"17","author":"T. Kafri","year":"1997","unstructured":"Kafri, T.; Blomer, U.; Peterson, D. A.; Gage, F. H.; Verma, I. M. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet 17: 314\u2013317; 1997 doi: 10.1038\/ng1197\u2013314 .","journal-title":"Nat. Genet"},{"key":"9138_CR12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmd.2004.10.009","volume":"15","author":"L. Klinge","year":"2005","unstructured":"Klinge, L.; Straub, V.; Neudorf, U.; Schaper, J.; Bosbach, T.; Gorlinger, K.; Wallot, M.; Richards, S.; Voit, T. Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. Neuromuscul. Disord. 15: 24\u201331; 2005 doi: 10.1016\/j.nmd.2004.10.009 .","journal-title":"Neuromuscul. Disord."},{"key":"9138_CR13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/CND.0b013e318176dbe4","volume":"9","author":"L. W. Katzin","year":"2008","unstructured":"Katzin, L. W.; Amato, A. A. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy. J. Clin. Neuromuscul. Dis 9: 421\u2013431; 2008 doi: 10.1097\/CND.0b013e318176dbe4 .","journal-title":"J. Clin. Neuromuscul. Dis"},{"key":"9138_CR14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"9","author":"P. S. Kishnani","year":"2007","unstructured":"Kishnani, P. S.; Corzo, D.; Nicolino, M.; Byrne, B.; Mandel, H.; Hwu, W. L.; Leslie, N.; Levine, J.; Spencer, C.; McDonald, M.; Li, J.; Dumontier, J.; Halberthal, M.; Chien, Y. H.; Hopkin, R.; Vijayaraghavan, S.; Gruskin, D.; Bartholomew, D.; van der Ploeg, A.; Clancy, J. P.; Parini, R.; Morin, G.; Beck, M.; De la Gastine, G. S.; Jokic, M.; Thurberg, B.; Richards, S.; Bali, D.; Davison, M.; Worden, M. A.; Chen, Y. T.; Wraith, J. E. Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 9: 99\u2013109; 2007 doi: 10.1212\/01.wnl.0000251268.41188.04 .","journal-title":"Neurology"},{"key":"9138_CR15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/6981","volume":"17","author":"E. Li","year":"1999","unstructured":"Li, E.; Eastman, M.; Schwartz, R. J.; Draghia-Akli, R. Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences. Nat. Biotechnol 17: 241\u2013245; 1999 doi: 10.1038\/6981 .","journal-title":"Nat. Biotechnol"},{"key":"9138_CR16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s001090050279","volume":"76","author":"C. Liu","year":"1998","unstructured":"Liu, C.; Bahnson, A. B.; Dunigan, J. T.; Watkins, S. C.; Barranger, J. A. Long-term expression and secretion of human glucocerebrosidase by primary murine and human myoblasts and differentiated myotubes. J. Mol. Med. 76: 773\u2013781; 1998 doi: 10.1007\/s001090050279 .","journal-title":"J. Mol. Med."},{"key":"9138_CR17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/1043034041648453","volume":"15","author":"Y. L. Liu","year":"2004","unstructured":"Liu, Y. L.; Mingozzi, F.; Rodriguez-Colon, S. M.; Joseph, S.; Dobrzynski, E.; Suzuki, T.; High, K. A.; Herzog, R. W. Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vector. Hum. Gene Ther 15: 783\u2013792; 2004 doi: 10.1089\/1043034041648453 .","journal-title":"Hum. Gene Ther"},{"key":"9138_CR18","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/hmg\/11.14.1637","volume":"11","author":"E. Martin-Touaux","year":"2002","unstructured":"Martin-Touaux, E.; Puech, J. P.; Chateau, D.; Emiliani, C.; Kremer, E. J.; Raben, N.; Tancini, B.; Orlacchio, A.; Kahn, A.; Poenaru, L. Muscle as a putative producer of acid alpha-glucosidase for glycogenosis type II gene therapy.. Hum. Mol. Genet 11: 1637\u20131645; 2002 doi: 10.1093\/hmg\/11.14.1637 .","journal-title":"Hum. Mol. Genet"},{"key":"9138_CR19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/dna.1991.10.283","volume":"10","author":"F. Martiniuk","year":"1991","unstructured":"Martiniuk, F.; Bodkin, M.; Tzall, S.; Hirschhorn, R. Isolation and partial characterization of the structural gene for human acid alpha glucosidase. DNA Cell Biol 10: 283\u2013292; 1991.","journal-title":"DNA Cell Biol"},{"key":"9138_CR20","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1182\/blood.V98.9.2664","volume":"98","author":"F. Moreau-Gaudry","year":"2001","unstructured":"Moreau-Gaudry, F.; Xia, P.; Jiang, G.; Perelman, N. P.; Bauer, G.; Ellis, J.; Surinya, K. H.; Mavilio, F.; Chen, C. K.; Malik, P. High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors. Blood 98: 2664\u20132672; 2001 doi: 10.1182\/blood.V98.9.2664 .","journal-title":"Blood"},{"key":"9138_CR21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/156652307780859044","volume":"7","author":"M. G. Ott","year":"2007","unstructured":"Ott, M. G.; Seger, R.; Stein, S.; Siler, U.; Hoelzer, D.; Grez, M. Advances in the treatment of chronic granulomatous disease by gene therapy. Curr. Gene Ther. 7: 155\u2013161; 2007 doi: 10.2174\/156652307780859044 .","journal-title":"Curr. Gene Ther."},{"key":"9138_CR22","volume-title":"Cell biology: a laboratory handbook","author":"C. Pinset","year":"1994","unstructured":"Pinset, C.; Montarras, D. Cell biology: a laboratory handbook. Academic, San Diego1994."},{"key":"9138_CR23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.mt.6300047","volume":"15","author":"S. P. Queneville","year":"2007","unstructured":"Queneville, S. P.; Chapdelaine, P.; Skuk, D.; Paradis, M.; Goulet, M.; Rousseau, J.; Xiao, X.; Garcia, L.; Tremblay, J. P. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models. Mol. Ther. 15: 431\u2013438; 2007 doi: 10.1038\/sj.mt.6300047 .","journal-title":"Mol. Ther."},{"key":"9138_CR24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","volume":"80","author":"N. Raben","year":"2003","unstructured":"Raben, N.; Danon, M.; Gilbert, A. L.; Dwivedi, S.; Collins, B.; Thurberg, B. L.; Mattaliano, R. J.; Nagaraju, K.; Plotz, P. H. Enzyme replacement therapy in the mouse model of Pompe disease. Mol. Genet Metab. 80: 159\u2013169; 2003 doi: 10.1016\/j.ymgme.2003.08.022 .","journal-title":"Mol. Genet Metab."},{"key":"9138_CR25","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","volume":"273","author":"N. Raben","year":"1998","unstructured":"Raben, N.; Nagaraju, K.; Lee, E.; Kessler, P.; Byrne, B.; Lee, L.; Lamarca, M.; King, C.; Ward, J.; Sauer, B.; Plotz, P. Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II.. J. Biol. Chem. 273: 19086\u201319092; 1998 doi: 10.1074\/jbc.273.30.19086 .","journal-title":"J. Biol. Chem."},{"key":"9138_CR26","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/sj.gt.3302335","volume":"11","author":"E. Richard","year":"2004","unstructured":"Richard, E.; Robert, E.; Cario-Andre, M.; Ged, C.; Geronimi, F.; Gerson, S. L.; de Verneuil, H.; Moreau-Gaudry, F. Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection. Gene Ther. 11: 1638\u20131647; 2004 doi: 10.1038\/sj.gt.3302335 .","journal-title":"Gene Ther."},{"key":"9138_CR27","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1128\/JVI.77.6.3495-3504.2003","volume":"77","author":"B. C. Schnepp","year":"2003","unstructured":"Schnepp, B. C.; Clark, K. R.; Klemanski, D. L.; Pacak, C. A.; Johnson, P. R. Genetic fate of recombinant adeno-associated virus vector genomes in muscle. J. Virol. 77: 3495\u20133504; 2003 doi: 10.1128\/JVI.77.6.3495-3504.2003 .","journal-title":"J. Virol."},{"key":"9138_CR28","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/522236","volume":"81","author":"B. Sun","year":"2007","unstructured":"Sun, B.; Bird, A.; Young, S. P.; Kishnani, P. S.; Chen, Y. T.; Koeberl, D. D. Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance. Am. J. Hum. Genet. 81: 1042\u20131049; 2007 doi: 10.1086\/522236 .","journal-title":"Am. J. Hum. Genet."},{"key":"9138_CR29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ymthe.2006.08.001","volume":"14","author":"B. Sun","year":"2006","unstructured":"Sun, B.; Zhang, H.; Benjamin, D. K. Jr; Brown, T.; Bird, A.; Young, S. P.; McVie-Wylie, A.; Chen, Y. T.; Koeberl, D. D. Enhanced efficacy of an AAV vector encoding chimeric, highly secreted acid alpha-glucosidase in glycogen storage disease type II. Mol. Ther. 14: 822\u2013830; 2006 doi: 10.1016\/j.ymthe.2006.08.001 .","journal-title":"Mol. Ther."},{"key":"9138_CR30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ymthe.2005.01.012","volume":"11","author":"B. Sun","year":"2005","unstructured":"Sun, B.; Zang, H.; Franco, L. M.; Brown, T.; Bird, A.; Schneider, A.; Koeberl, D. D. Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter. Mol. Ther. 11: 889\u2013898; 2005b doi: 10.1016\/j.ymthe.2005.01.012 .","journal-title":"Mol. Ther."},{"key":"9138_CR31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymthe.2004.10.004","volume":"11","author":"B. Sun","year":"2005","unstructured":"Sun, B.; Zhang, H.; Franco, L. M.; Young, S. P.; Schneider, A.; Bird, A.; Amalfitano, A.; Chen, Y. T.; Koeberl, D. D. Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II.. Mol. Ther. 11: 57\u201365; 2005a doi: 10.1016\/j.ymthe.2004.10.004 .","journal-title":"Mol. Ther."},{"key":"9138_CR32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cccn.2005.05.025","volume":"361","author":"K. Umapathysivam","year":"2005","unstructured":"Umapathysivam, K.; Hopwood, J. J.; Meikle, P. J. Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease. Clin. Chim. Acta 361: 191\u2013198; 2005 doi: 10.1016\/j.cccn.2005.05.025 .","journal-title":"Clin. Chim. Acta"},{"key":"9138_CR33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0022-510X(87)90239-5","volume":"79","author":"A. T. Ploeg Van der","year":"1987","unstructured":"Van der Ploeg, A. T.; Kroos, M.; van Dongen, J. M.; Visser, W. J.; Bolhuis, P. A.; Loonen, M. C.; Reuser, A. J. Breakdown of lysosomal glycogen in cultured fibroblasts from glycogenosis type II patients after uptake of acid alpha-glucosidase. J. Neurol. Sci. 79: 327\u2013336; 1987 doi: 10.1016\/0022-510X(87)90239-5 .","journal-title":"J. Neurol. Sci."},{"key":"9138_CR34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20019","volume":"55","author":"A. T. Ploeg Van der","year":"2004","unstructured":"Van der Ploeg, A. T.; Winkel, L. P.; Van den Hout, J. M.; Kamphoven, J. H.; Disseldorp, J. A.; Remmerswaal, M.; Arts, W. F.; Loonen, M. C.; Vulto, A. G.; Van Doorn, P. A.; de Jong, G.; Hop, W.; Smit, G. P.; Shapira, S. K.; Boer, M. A.; Van Diggelen, O. P.; Reuser, A. J. Enzyme replacement therapy in late-onset Pompe\u2019s disease: a three-year follow-up.. Ann. Neurol. 55: 495\u2013502; 2004 doi: 10.1002\/ana.20019 .","journal-title":"Ann. Neurol."},{"key":"9138_CR35","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/JVI.73.3.1949-1955.1999","volume":"73","author":"N. Vincent-Lacaze","year":"1999","unstructured":"Vincent-Lacaze, N.; Snyder, R. O.; Gluzman, R.; Bohl, D.; Lagarde, C.; Danos, O. Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J. Virol 73: 1949\u20131955; 1999.","journal-title":"J. Virol"},{"key":"9138_CR36","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0021-9258(18)53985-5","volume":"268","author":"H. A. Wisselaar","year":"1993","unstructured":"Wisselaar, H. A.; Kroos, M. A.; Hermans, M. M.; van Beeumen, J.; Reuser, A. J. Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation. J. Biol. Chem. 268: 2223\u20132231; 1993.","journal-title":"J. Biol. Chem."},{"key":"9138_CR37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jgm.660","volume":"7","author":"F. Xu","year":"2005","unstructured":"Xu, F.; Ding, E.; Migone, F.; Serra, D.; Schneider, A.; Chen, Y. T.; Amalfitano, A. Glycogen storage in multiple muscles of old GSD-II mice can be rapidly cleared after a single intravenous injection with a modified adenoviral vector expressing hGAA. J. Gene Med. 7: 171\u2013178; 2005 doi: 10.1002\/jgm.660 .","journal-title":"J. Gene Med."},{"key":"9138_CR38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.gt.3303082","volume":"15","author":"A. Zaldumbide","year":"2008","unstructured":"Zaldumbide, A.; Hoeben, R. C. How not to be seen: immune-evasion strategies in gene therapy. Gene Ther. 15: 239\u2013246; 2008 doi: 10.1038\/sj.gt.3303082 .","journal-title":"Gene Ther."},{"key":"9138_CR39","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1089\/hum.1997.8.13-1555","volume":"8","author":"J. Z. Zaretzky","year":"1997","unstructured":"Zaretzky, J. Z.; Candotti, F.; Boerkoel, C.; Adams, E. M.; Yewdell, J. W.; Blaese, R. M.; Plotz, P. H. Retroviral transfer of acid alpha-glucosidase cDNA to enzyme-deficient myoblasts results in phenotypic spread of the genotypic correction by both secretion and fusion. Hum. Gene Ther. 8: 1555\u20131563; 1997 doi: 10.1089\/hum.1997.8.13-1555 .","journal-title":"Hum. Gene Ther."},{"key":"9138_CR40","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/hum.2008.010","volume":"19","author":"R. J. Ziegler","year":"2008","unstructured":"Ziegler, R. J.; Bercury, S. D.; Fidler, J.; Zhao, M. A.; Foley, J.; Taksir, T. V.; Ryan, S.; Hodges, B. L.; Scheule, R. K.; Shihabuddin, L. S.; Cheng, S. H. Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid alpha-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe mice. Hum. Gene Ther. 19: 609\u2013721; 2008 doi: 10.1089\/hum.2008.010 .","journal-title":"Hum. Gene Ther."},{"key":"9138_CR41","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/JVI.73.4.2886-2892.1999","volume":"73","author":"R. Zufferey","year":"1999","unstructured":"Zufferey, R.; Donello, J. E.; Trono, D.; Hope, T. J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73: 2886\u20132892; 1999.","journal-title":"J. Virol."},{"key":"9138_CR42","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","volume":"72","author":"R. Zufferey","year":"1998","unstructured":"Zufferey, R.; Dull, T.; Mandel, R. J.; Bukovsky, A.; Quiroz, D.; Naldini, L.; Trono, D. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72: 9873\u20139880; 1998.","journal-title":"J. Virol."}],"container-title":["In Vitro Cellular & Developmental Biology - Animal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-008-9138-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11626-008-9138-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-008-9138-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:43:24Z","timestamp":1631839404000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11626-008-9138-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,23]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["9138"],"URL":"https:\/\/doi.org\/10.1007\/s11626-008-9138-5","relation":{},"ISSN":["1071-2690","1543-706X"],"issn-type":[{"value":"1071-2690","type":"print"},{"value":"1543-706X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,23]]}}}